$RXRX ($RXRX) posted quarterly earnings results for Q4 2025 on Wednesday, February 25th. The company reported earnings of -$0.21 per share, beating estimates of -$0.32 by $0.11. The company also reported revenue of $35,540,000, beating estimates of $25,077,424 by $10,462,576.
You can see Quiver Quantitative's $RXRX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
$RXRX Insider Trading Activity
$RXRX insiders have traded $RXRX stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $RXRX stock by insiders over the last 6 months:
- CHRISTOPHER GIBSON has made 0 purchases and 12 sales selling 720,000 shares for an estimated $3,513,000.
- BLAKE BORGESON has made 0 purchases and 3 sales selling 660,000 shares for an estimated $2,844,600.
- NAJAT KHAN (Chief R&D Commercial Officer) sold 124,403 shares for an estimated $548,592
- BEN R TAYLOR (Chief Financial Officer) has made 0 purchases and 2 sales selling 34,809 shares for an estimated $130,733.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RXRX Hedge Fund Activity
We have seen 184 institutional investors add shares of $RXRX stock to their portfolio, and 177 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MUBADALA INVESTMENT CO PJSC removed 12,985,927 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $53,112,441
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 12,712,693 shares (-75.7%) from their portfolio in Q4 2025, for an estimated $51,994,914
- NVIDIA CORP removed 7,706,363 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $31,519,024
- VANGUARD GROUP INC added 7,407,606 shares (+18.6%) to their portfolio in Q4 2025, for an estimated $30,297,108
- BLACKROCK, INC. added 7,127,014 shares (+22.5%) to their portfolio in Q4 2025, for an estimated $29,149,487
- STATE STREET CORP added 7,064,963 shares (+38.7%) to their portfolio in Q4 2025, for an estimated $28,895,698
- ARK INVESTMENT MANAGEMENT LLC added 3,771,357 shares (+11.2%) to their portfolio in Q4 2025, for an estimated $15,424,850
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RXRX Analyst Ratings
Wall Street analysts have issued reports on $RXRX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 12/17/2025
- Needham issued a "Buy" rating on 09/11/2025
To track analyst ratings and price targets for $RXRX, check out Quiver Quantitative's $RXRX forecast page.
$RXRX Price Targets
Multiple analysts have issued price targets for $RXRX recently. We have seen 2 analysts offer price targets for $RXRX in the last 6 months, with a median target of $9.5.
Here are some recent targets:
- Eric Joseph from JP Morgan set a target price of $11.0 on 12/17/2025
- Gil Blum from Needham set a target price of $8.0 on 09/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
